United Kingdom· GB-APID-14489811000001100
Celance 250microgram tablets
A pergolide product containing pergolide, registered in United Kingdom by Sigma Pharmaceuticals Plc. The same ATC class is registered in 3 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Pergolide is registered in 3 of 19 countries.
Countries holding a registration under ATC N04BC02 (pergolide), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 1 of them publish a price we can compare per daily dose
Pergolide · ATC N04BC02
3 / 19 countries
- Finlandprice
- Japan
- United Kingdom
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Pergolide
- Manufacturer
- Sigma Pharmaceuticals Plc
- Country
- United Kingdom (GB)
- ATC code
- N04BC02
- ATC class
- Pergolide
- Defined daily dose
- 3 mg, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
81 interactions on record for pergolide.
Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Pergolide · interactions on record
81 records
- 1 severe
- 55 moderate
- 25 info
Most severe, free to view
- LorcaserinA08AA11severe
- MetoclopramideA03FA01moderate
- ThiethylperazinA04AB03moderate
- DiphenhydraminA04AB05moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Pergolide in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5f373d6e-bf93-4599-b2b5-a9f7afd7bcbb GET /v1/drugs/5f373d6e-bf93-4599-b2b5-a9f7afd7bcbb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "14489811000001100",
"desc": "Celance 250microgram tablets (Sigma Pharmaceuticals Plc)",
"form": "Oral tablet",
"vpid": "39702311000001107",
"source": "dmd",
"vtm_id": "777139007",
"strength": "250 microgram",
"substance": "Pergolide",
"ingredient": "Pergolide mesilate",
"supplier_code": "2087601000001106"
}See everything about pergolide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.